139 related articles for article (PubMed ID: 33676357)
41. Xanthogranulomatous cholecystitis: diagnostic performance of US, CT, and MRI for differentiation from gallbladder carcinoma.
Lee ES; Kim JH; Joo I; Lee JY; Han JK; Choi BI
Abdom Imaging; 2015 Oct; 40(7):2281-92. PubMed ID: 25952571
[TBL] [Abstract][Full Text] [Related]
42. Elevated bile amylase level without pancreaticobiliary maljunction is a risk factor for gallbladder carcinoma.
Fujimoto T; Ohtsuka T; Nakashima Y; Gotoh Y; Date K; Mori Y; Sadakari Y; Takahata S; Oda Y; Nakamura M
J Hepatobiliary Pancreat Sci; 2017 Feb; 24(2):103-108. PubMed ID: 28002646
[TBL] [Abstract][Full Text] [Related]
43. Contrast-enhanced ultrasound for differentiating benign from malignant solid small renal masses: comparison with contrast-enhanced CT.
Wei SP; Xu CL; Zhang Q; Zhang QR; Zhao YE; Huang PF; Xie YD; Zhou CS; Tian FL; Yang B
Abdom Radiol (NY); 2017 Aug; 42(8):2135-2145. PubMed ID: 28331942
[TBL] [Abstract][Full Text] [Related]
44. Nomogram to predict overall survival after gallbladder cancer resection in China.
Bai Y; Liu ZS; Xiong JP; Xu WY; Lin JZ; Long JY; Miao F; Huang HC; Wan XS; Zhao HT
World J Gastroenterol; 2018 Dec; 24(45):5167-5178. PubMed ID: 30568393
[TBL] [Abstract][Full Text] [Related]
45. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
46. Significance of Metabolic Tumor Volume and Total Lesion Glycolysis Measured Using ¹⁸F-FDG PET/CT in Locally Advanced and Metastatic Gallbladder Carcinoma.
Chun YJ; Jeung HC; Park HS; Park JS; Rha SY; Choi HJ; Lee JH; Jeon TJ
Yonsei Med J; 2019 Jul; 60(7):604-610. PubMed ID: 31250573
[TBL] [Abstract][Full Text] [Related]
47. Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET/CT as a new diagnostic avenue.
Krishnaraju VS; Kumar R; Mittal BR; Sharma V; Singh H; Nada R; Bal A; Rohilla M; Singh H; Rana SS
Eur Radiol; 2021 Apr; 31(4):2199-2208. PubMed ID: 33001304
[TBL] [Abstract][Full Text] [Related]
48. CT of gallbladder cancer and its mimics: a pattern-based approach.
Deshmukh SD; Johnson PT; Sheth S; Hruban R; Fishman EK
Abdom Imaging; 2013 Jun; 38(3):527-36. PubMed ID: 22581235
[TBL] [Abstract][Full Text] [Related]
49. Imaging and Screening of Cancer of the Gallbladder and Bile Ducts.
Sandrasegaran K; Menias CO
Radiol Clin North Am; 2017 Nov; 55(6):1211-1222. PubMed ID: 28991561
[TBL] [Abstract][Full Text] [Related]
50. Xanthogranulomatous cholecystitis: diagnostic performance of CT to differentiate from gallbladder cancer.
Goshima S; Chang S; Wang JH; Kanematsu M; Bae KT; Federle MP
Eur J Radiol; 2010 Jun; 74(3):e79-83. PubMed ID: 19446416
[TBL] [Abstract][Full Text] [Related]
51. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions.
Ozcan Kara P; Kara T; Kara Gedik G; Kara F; Sahin O; Ceylan Gunay E; Sari O
Nucl Med Commun; 2011 Feb; 32(2):106-12. PubMed ID: 21085046
[TBL] [Abstract][Full Text] [Related]
52. Appendiceal mucocele: A diagnostic dilemma in differentiating malignant from benign lesions with CT.
Wang H; Chen YQ; Wei R; Wang QB; Song B; Wang CY; Zhang B
AJR Am J Roentgenol; 2013 Oct; 201(4):W590-5. PubMed ID: 24059397
[TBL] [Abstract][Full Text] [Related]
53. Differentiating malignant from benign thickening of the gallbladder wall by the use of acoustic radiation force impulse elastography.
Kapoor A; Kapoor A; Mahajan G
J Ultrasound Med; 2011 Nov; 30(11):1499-507. PubMed ID: 22039022
[TBL] [Abstract][Full Text] [Related]
54. Accuracy of preoperative T-staging of gallbladder carcinoma using MDCT.
Kim SJ; Lee JM; Lee JY; Choi JY; Kim SH; Han JK; Choi BI
AJR Am J Roentgenol; 2008 Jan; 190(1):74-80. PubMed ID: 18094296
[TBL] [Abstract][Full Text] [Related]
55. Application of modern imaging methods in diagnosis of gallbladder cancer.
Rodríguez-Fernández A; Gómez-Río M; Medina-Benítez A; Moral JV; Ramos-Font C; Ramia-Angel JM; Llamas-Elvira JM; Ferrón-Orihuela JA; Lardelli-Claret P
J Surg Oncol; 2006 Jun; 93(8):650-64. PubMed ID: 16724342
[TBL] [Abstract][Full Text] [Related]
56. CT evaluation of small polypoid lesions of the gallbladder.
Furukawa H; Takayasu K; Mukai K; Inoue K; Kyokane T; Shimada K; Kosuge T; Ushio K
Hepatogastroenterology; 1995; 42(6):800-10. PubMed ID: 8847027
[TBL] [Abstract][Full Text] [Related]
57. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
[TBL] [Abstract][Full Text] [Related]
58. Prognostic significance of combined preoperative fibrinogen and CA199 in gallbladder cancer patients.
Xu WY; Zhang HH; Yang XB; Bai Y; Lin JZ; Long JY; Xiong JP; Zhang JW; Sang XT; Zhao HT
World J Gastroenterol; 2018 Apr; 24(13):1451-1463. PubMed ID: 29632426
[TBL] [Abstract][Full Text] [Related]
59. Treatment of advanced gallbladder cancer: A SEER-based study.
Mao W; Deng F; Wang D; Gao L; Shi X
Cancer Med; 2020 Jan; 9(1):141-150. PubMed ID: 31721465
[TBL] [Abstract][Full Text] [Related]
60. Laparoscopic cholecystectomy can disseminate in situ carcinoma of the gallbladder.
Wibbenmeyer LA; Wade TP; Chen RC; Meyer RC; Turgeon RP; Andrus CH
J Am Coll Surg; 1995 Dec; 181(6):504-10. PubMed ID: 7582223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
